Xeris Biopharma Holdings, Inc. XERS Enterprise value

Enterprise value at other companies

Eli LillyLLY

$1.12T+51.8%

Corcept TherapeuticsCORT

$9.23B+14.7%

Eton Pharmaceuticals, Inc.ETON

$684.98M+89.8%

Zevra Therapeutics, Inc.ZVRA

$703.89M+36.7%

Ultragenyx PharmaceuticalRARE

$1.83B-51.1%

ANI PharmaceuticalsANIP

$1.82B+17.9%

FAQ

What is Xeris Biopharma Holdings, Inc.'s enterprise value?

Xeris Biopharma Holdings, Inc. (XERS) reported enterprise value of $1.54B in Q2 2026.

How has Xeris Biopharma Holdings, Inc.'s enterprise value changed year-over-year?

Xeris Biopharma Holdings, Inc.'s enterprise value increased by 62.6% year-over-year, from $944.26M to $1.54B.

What is the long-term trend for Xeris Biopharma Holdings, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s enterprise value has grown at a 16.9% compound annual growth rate (CAGR), from $662.99M to $1.45B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.